Scinai Immunotherapeutics (SCNI) Enterprise Value (2016 - 2025)

Scinai Immunotherapeutics has disclosed Enterprise Value across 10 years of filings, most recently posting -$2.0 billion for Q4 2025.

• Enterprise Value for Q4 2025 came in at -$2.0 billion, down 96900.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.0 billion (down 96900.0% YoY), and the FY2025 annual result was -$2.0 billion, down 96900.0% from the prior year.
• Enterprise Value came in at -$2.0 billion for Q4 2025 at Scinai Immunotherapeutics, down from -$1.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$1.1 million in Q2 2025 to a low of -$48.6 billion in Q1 2021.
• The 5-year median for Enterprise Value is -$8.0 million (2022), against an average of -$2.8 billion.
• Across the five-year window, Enterprise Value plunged 114285278.19% in 2021 and jumped 99.97% in 2022, its largest moves.
• Scinai Immunotherapeutics' Enterprise Value stood at -$17.5 million in 2021, then advanced by 18.85% to -$14.2 million in 2022, then soared by 64.76% to -$5.0 million in 2023, then jumped by 58.18% to -$2.1 million in 2024, then tumbled by 96900.0% to -$2.0 billion in 2025.
• The last three Enterprise Value figures came in at -$2.0 billion (Q4 2025), -$1.1 million (Q2 2025), and -$2.1 million (Q4 2024), per Business Quant data.